Literature DB >> 1536109

Prognostic value of exercise thallium scintigraphy in patients with good exercise tolerance and a normal or abnormal exercise electrocardiogram and suspected or confirmed coronary artery disease.

L F Fagan1, L Shaw, B A Kong, D G Caralis, R D Wiens, B R Chaitman.   

Abstract

Exercise thallium scintigraphy is widely used to assess prognosis in patients with suspected or proven coronary artery disease. The incremental prognostic value of this technique in patients who have good exercise tolerance has not been well studied. Two hundred ninety-nine patients with known or suspected coronary artery disease without prior myocardial infarction or revascularization procedure referred for exercise myocardial perfusion imaging and able to exercise to greater than or equal to stage III of the Bruce protocol were included. After a mean follow-up of 50 +/- 10 months, there were 15 cardiac events (5%). The incidence of cardiac events was 10 versus 3% (p less than 0.001) in patients with an abnormal versus normal thallium-201 scan, and 9 versus 3% (p = 0.03) for an abnormal versus normal exercise electrocardiogram. When the 185 patients with a normal exercise electrocardiogram were examined, the incidence of cardiac events was 3% (5 of 150) in patients with a normal scan versus 0% (0 of 35) in patients with an abnormal scan. In the 114 patients with an abnormal exercise electrocardiogram, an abnormal thallium-201 scan was predictive of cardiac events (18% [8 of 44] versus 3% [2 of 70]; p = 0.006). Stepwise logistic regression analysis selected an abnormal thallium-201 scan and abnormal exercise electrocardiogram, low peak exercise heart rate, and male gender as independent variables associated with a significant increased risk of cardiac events. Thus, in patients with known or suspected coronary artery disease and good exercise tolerance, the addition of thallium-201 imaging in patients with an abnormal exercise electrocardiogram provides useful prognostic information.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536109     DOI: 10.1016/0002-9149(92)90150-w

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Post-myocardial infarction risk stratification with stress nuclear myocardial perfusion imaging versus echocardiography: separate but not equal.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 2.  An overview of radiotracers in nuclear cardiology.

Authors:  W Acampa; C Di Benedetto; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 3.  The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging.

Authors:  Elizabeth M Cosmai; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

4.  Diagnostic and prognostic exercise electrocardiography: what can nuclear cardiology gain from insights from the exercise laboratory--challenge and speculation.

Authors:  B R Chaitman; D D Miller
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

5.  The mystery poor prognosticator! Pharmacologic stress MPI prevalence and predictors: Insights from the Middle East.

Authors:  Mohamed Mandour Ali; Adel H Allam
Journal:  J Nucl Cardiol       Date:  2018-01-16       Impact factor: 5.952

6.  Arm exercise stress perfusion imaging predicts clinical outcome.

Authors:  Albert K Chan; Nasreen A Ilias-Khan; Hong Xian; Cindi Inman; Wade H Martin
Journal:  J Appl Physiol (1985)       Date:  2011-08-18

Review 7.  Prognostic value of myocardial perfusion imaging: state of the art and new developments.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

8.  Prognostic value of myocardial hypoperfusion indexes in patients with suspected or known coronary artery disease.

Authors:  M Petretta; A Cuocolo; A Carpinelli; E Nicolai; G Valva; V Bianchi; L Salemme; M Salvatore; D Bonaduce
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

9.  Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis.

Authors:  Sachin M Navare; Jeff F Mather; Leslee J Shaw; Michael S Fowler; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

10.  Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging.

Authors:  Brian G Abbott; Maryam Afshar; Alan K Berger; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.